Differentiating intraocular glucocorticoids
- PMID: 20714178
- DOI: 10.1159/000315158
Differentiating intraocular glucocorticoids
Abstract
Background: Natural corticosteroids (e.g. hydrocortisone) and synthetic selective glucocorticoid (GC) agonists have been used by ophthalmologists for decades to treat various forms of ocular inflammation. More recently, increased clinical use of locally delivered GC has shown significant benefit for the treatment of multiple retinal indications including macular edema associated with uveitis, retinal vascular occlusions and diabetes. Our current understanding of the clinical utility of specific intraocular GC far surpasses our knowledge of their biologic and pharmacologic activities in the eye.
Objective: To present an update on GC receptor (GR) biology in general and as it applies to the eye, and discuss the pharmacokinetics, delivery and pharmacology of the commonly used intraocular GC dexamethasone (DEX), triamcinolone acetonide (TA) and fluocinolone acetonide (FA).
Results: DEX, TA and FA are structurally similar but significantly differentiated by their aqueous and lipid solubility, delivery system requirements, pharmacokinetics and interactions with functional GR. Culture of human trabecular meshwork cells and full transcriptome microarray analysis reveals that DEX, TA and FA generate unique gene transactivation and repression profiles as well as potentially distinct biologic responses that are not only steroid structure dependent, but also dose and time dependent. Finally, DEX and FA markedly protect photoreceptors from degenerating in animal models of excessive light and retinitis pigmentosa, respectively.
Conclusion: It is tempting to speculate that the unique pharmacokinetic and pharmacologic profiles of the commonly used intraocular steroids and novel future drugs may reveal significant differences in their therapeutic value in patients with macular edema or other inflammatory disease, in their ocular adverse side effect profile, and their ability to normalize glial and neuronal function in diseased retina.
Copyright 2010 S. Karger AG, Basel.
Similar articles
-
Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.Exp Eye Res. 2002 Jan;74(1):51-9. doi: 10.1006/exer.2001.1098. Exp Eye Res. 2002. PMID: 11878818
-
Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells.Invest Ophthalmol Vis Sci. 1994 Jan;35(1):281-94. Invest Ophthalmol Vis Sci. 1994. PMID: 8300356
-
Intraocular availability of triamcinolone acetonide after intravitreal injection.Am J Ophthalmol. 2004 Mar;137(3):560-2. doi: 10.1016/j.ajo.2003.08.012. Am J Ophthalmol. 2004. PMID: 15013884
-
Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.Prog Retin Eye Res. 2005 Sep;24(5):587-611. doi: 10.1016/j.preteyeres.2005.01.004. Epub 2005 Mar 29. Prog Retin Eye Res. 2005. PMID: 16005407 Review.
-
The use of intraocular corticosteroids.Expert Opin Pharmacother. 2009 Oct;10(15):2511-25. doi: 10.1517/14656560903160671. Expert Opin Pharmacother. 2009. PMID: 19761356 Review.
Cited by
-
An eighteen-month follow-up study on the effects of Intravitreal Dexamethasone Implant in diabetic macular edema refractory to anti-VEGF therapy.Int J Ophthalmol. 2016 Oct 18;9(10):1427-1432. doi: 10.18240/ijo.2016.10.10. eCollection 2016. Int J Ophthalmol. 2016. PMID: 27803859 Free PMC article.
-
Pharmacology of Corticosteroids for Diabetic Macular Edema.Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):1-12. doi: 10.1167/iovs.17-22259. Invest Ophthalmol Vis Sci. 2018. PMID: 29297055 Free PMC article. Review.
-
Efficacy and Safety of Ophthalmic Steroids in the Management of Polypoidal Choroidal Vasculopathy: A Systematic Review.Clin Ophthalmol. 2025 Mar 15;19:915-931. doi: 10.2147/OPTH.S517296. eCollection 2025. Clin Ophthalmol. 2025. PMID: 40110363 Free PMC article. Review.
-
Fluocinolone acetonide and its potential in the treatment of chronic diabetic macular edema.Clin Ophthalmol. 2013;7:503-9. doi: 10.2147/OPTH.S34057. Epub 2013 Mar 8. Clin Ophthalmol. 2013. PMID: 23503099 Free PMC article.
-
Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts.Arch Ophthalmol. 2011 Jul;129(7):914-20. doi: 10.1001/archophthalmol.2011.39. Epub 2011 Mar 14. Arch Ophthalmol. 2011. PMID: 21402977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous